Status:

COMPLETED

VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Anxiety

Eligibility:

All Genders

7-13 years

Phase:

NA

Brief Summary

Objective: 1. To evaluate the efficacy of a school-based cognitive behavior therapy (CBT) program in reducing anxiety disorder symptoms in at-risk public school children. 2. To determine whether pare...

Eligibility Criteria

Inclusion

  • Children enrolled in school between the ages of 7 and 13 who display anxiety symptoms.
  • Anxiety disorder symptoms (identified by a score of 56 or higher on the MASC; and teacher report, and /or parent recommendation) as the primary presenting problem. An enrolled child must have at least 2 of these criterions.
  • Fluency in English.
  • Parent willingness to sign consent form and to complete required assessments.
  • Student willingness to participate (child assent) in 10-week affective education program and completion of required assessments.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2002

    Trial Type :

    INTERVENTIONAL

    End Date :

    June 1 2005

    Estimated Enrollment :

    281 Patients enrolled

    Trial Details

    Trial ID

    NCT00247754

    Start Date

    November 1 2002

    End Date

    June 1 2005

    Last Update

    November 2 2005

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of British Columbia, Faculty of Education

    Vancouver, British Columbia, Canada, V6T 1Z4

    VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children) | DecenTrialz